Visitor info Book a COVID-19 test COVID-19 vaccine info

Inventing the Future of Health Care for Ontario and Beyond: Strategic Plan 2018-21
Share:  
|

Read the article »
World first: focused ultrasound opens blood-brain barrier for delivery of therapeutic in Parkinson's disease

Click here to read a text-only version of this infographic

Strategic Direction 1: Personalized and Precise Treatments

Operational Excellence

Indicator: Alternate Level of Care (ALC) rate in acute care medical and surgical beds (%)
2018/19 Results: 16.9%
2019/20 Results: 13.9%
2020/21 Results: 11.2 %
2018/19 Target: ≤16%
2019/20 Target: ≤ 13%
2020/21 Target: ≤10%

Indicator: Median Emergency Department LOS for Admitted patients (Hours)
2018/19 Results: 16.5
2019/20 Results: 15.9
2020/21 Results: 13.5
2018/19 Target: ≤14.5
2019/20 Target: ≤14.5
2020/21 Target: ≤12.5

Indicator: Answer to the question: “Does Sunnybrook have a balanced budget and is it achieving or exceeding its balanced budget financial position?” (Yes/No)
2018/19 Results: Yes (reached target)
2019/20 Results: Yes (reached target)
2020/21 Results: Yes (reached target)
Target: Yes

Indicator: eDischarge Summaries completed within 48 hours (%)
2018/19 Results: 78.5%
2019/20 Results: 79.2%
2020/21 Results: 82.6%
2018/19 Target: ≥80%
2019/20 Target: ≥85%
2020/21 Target: ≥90%

Indicator: Patient Response to "How often did staff work with you to act on what was important to you?" (%)
2018/19 Results: 63.9%
2019/20 Results: 65.5%
2020/21 Results: 49.0%
2018/19 Target: ≥ 64.1%
2019/20 Target: ≥ 67.1%
2020/21 Target: ≥ 70.2%

Strategic Direction 1: Personalized & Precise Treatments

Goal 1: Advance support for discovery and technology development in molecular and image guided diagnostics and therapeutics; and population health research and analytics
Performance Indicator: Number of pre-clinical trials initiated in Personalized & Precise Treatments (PPT) (#)
2018/19 Results: 15
2019/20 Results: 19 (reached target)
2020/21 Results: 14
2018/19 Target: ≥16
2019/20 Target: ≥16
2020/21 Target: ≥17

Goal 2: Lead in the translation and implementation of new personalized and precise diagnostics and therapeutics and minimally invasive interventions
Performance Indicator: Number of new clinical trials initiated in Personalized & Precise Treatments (PPT) (#)
2018/19 Results: 25 (reached target)
2019/20 Results: 17 (reached target)
2020/21 Results: 30 (reached target)
2018/19 Target: ≥16
2019/20 Target: ≥17
2020/21 Target: ≥18

Goal 3: Lead in the adoption and spread of new models of care in personalized and precise diagnostics and therapeutics and minimally invasive interventions
Performance Indicator: Number of PPT interventions implemented at Sunnybrook (#)
2018/19 Results: 1(cumulative) (reached target)
2019/20 Results: 2 (cumulative) (reached target)
2020/21 Results: 2(cumulative)
2018/19 Target: ≥1 (cumulative)
2019/20 Target: ≥2 (cumulative)
2020/21 Target: ≥3 (cumulative)

Illustrating Progress
World first: focused ultrasound opens blood-brain barrier for delivery of therapeutic in Parkinson's disease


Next »